Other
Virus
0
Pipeline Programs↗
0
Active Trials↗
3
Companies Involved↗
Virus is an early-stage landscape with 0 programs across 3 companies. The most active players are Sanofi, Pfizer, Novartis.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
37
clinical trials
Completed30 · 81%
Unknown status5 · 14%
Withdrawn1 · 3%
Terminated1 · 3%
Clinical Trials
Trial Activity
37 trials
H1N1v Virus Challenge Study in Healthy Subjects
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT04044352·76 enrolled
Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00405821·440 enrolled
Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)
Completed·—·Phase 1·NCT01435811·60 enrolled
New Challenge Pool of Norwalk Virus Inoculum
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00138476·57 enrolled
Phase I Norovirus Challenge Model
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT04174560·48 enrolled
Administration of Virus-Specific Cytotoxic T-Lymphocytes
Completed·—·Phase 1·NCT00590083·14 enrolled
Multivirus-specific Cytotoxic T Lymphocytes (mCTL)
Completed·—·Phase 1·NCT02510404·1 enrolled
Effect of Mouthwash in Reducing the Symptoms Associated With Flu and Cold Viruses
Completed·—·Phase 3·NCT06479226·150 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)